Citadel Advisors
BTX.WS

Citadel Advisors’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Citadel Advisors’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-164
Closed – – 9035
2014
Q4 		$0 Buy
+164
New +$178 ﹤0.01% 8880

Other funds holding BTX.WS

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Citadel Advisors's BTX.WS Position: Q1 2015 in Review

Citadel Advisors sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q1 2015, closing a stake of 164 shares.

Citadel Advisors first reported a position in BTX.WS in Q4 2014 and held it in 1 quarter. The position peaked at $0 in Q4 2014. 32 funds tracked by Wall St. Rank hold BTX.WS as of Q1 2015.

  • Citadel Advisors reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q1 2015 after selling out during the quarter.
  • Citadel Advisors sold 164 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q1 2015.
  • Citadel Advisors first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 1 quarter.
  • Citadel Advisors's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q4 2014.
  • 32 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.